In this section of the review, we will first delve into two of glioblastoma multiforme’s most important immune evasion mechanisms: the control of the tumor microenvironment (TME) to diligently suppress pro-inflammatory leukocytes and the use of checkpoint molecules such as PD-L1 to escape the cytotoxicity of lymphocytes. This evidence concerns the gene CD274 and glioblastoma.